Literature DB >> 23046267

The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans.

Warwick B Dunn1, Ian D Wilson, Andrew W Nicholls, David Broadhurst.   

Abstract

The metabolic investigation of the human population is becoming increasingly important in the study of health and disease. The phenotypic variation can be investigated through the application of metabolomics; to provide a statistically robust investigation, the study of hundreds to thousands of individuals is required. In untargeted and MS-focused metabolomic studies this once provided significant hurdles. However, recent innovations have enabled the application of MS platforms in large-scale, untargeted studies of humans. Herein we describe the importance of experimental design, the separation of the biological study into multiple analytical experiments and the incorporation of QC samples to provide the ability to perform signal correction in order to reduce analytical variation and to quantitatively determine analytical precision. In addition, we describe how to apply this in quality assurance processes. These innovations have opened up the capabilities to perform routine, large-scale, untargeted, MS-focused studies.

Entities:  

Mesh:

Year:  2012        PMID: 23046267     DOI: 10.4155/bio.12.204

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  115 in total

1.  Ontology-based metabolomics data integration with quality control.

Authors:  Patricia Buendia; Ray M Bradley; Thomas J Taylor; Emma L Schymanski; Gary J Patti; Mansur R Kabuka
Journal:  Bioanalysis       Date:  2019-06-10       Impact factor: 2.681

2.  Technical Challenges in Mass Spectrometry-Based Metabolomics.

Authors:  Fumio Matsuda
Journal:  Mass Spectrom (Tokyo)       Date:  2016-11-25

3.  Miniaturized 1H-NMR method for analyzing limited-quantity samples applied to a mouse model of Leigh disease.

Authors:  Shayne Mason; Karin Terburgh; Roan Louw
Journal:  Metabolomics       Date:  2018-05-21       Impact factor: 4.290

Review 4.  The use of mass spectrometry for analysing metabolite biomarkers in epidemiology: methodological and statistical considerations for application to large numbers of biological samples.

Authors:  Mads V Lind; Otto I Savolainen; Alastair B Ross
Journal:  Eur J Epidemiol       Date:  2016-05-26       Impact factor: 8.082

5.  Untargeted metabolomic analysis and pathway discovery in perinatal asphyxia and hypoxic-ischaemic encephalopathy.

Authors:  Niamh M Denihan; Jennifer A Kirwan; Brian H Walsh; Warwick B Dunn; David I Broadhurst; Geraldine B Boylan; Deirdre M Murray
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-25       Impact factor: 6.200

Review 6.  Review of recent developments in GC-MS approaches to metabolomics-based research.

Authors:  David J Beale; Farhana R Pinu; Konstantinos A Kouremenos; Mahesha M Poojary; Vinod K Narayana; Berin A Boughton; Komal Kanojia; Saravanan Dayalan; Oliver A H Jones; Daniel A Dias
Journal:  Metabolomics       Date:  2018-11-17       Impact factor: 4.290

7.  Statistically Driven Metabolite and Lipid Profiling of Patients from the Undiagnosed Diseases Network.

Authors:  Bobbie-Jo M Webb-Robertson; Kelly G Stratton; Jennifer E Kyle; Young-Mo Kim; Lisa M Bramer; Katrina M Waters; David M Koeller; Thomas O Metz
Journal:  Anal Chem       Date:  2019-12-05       Impact factor: 6.986

Review 8.  A review of metabolomics approaches and their application in identifying causal pathways of childhood asthma.

Authors:  Kedir N Turi; Lindsey Romick-Rosendale; Kelli K Ryckman; Tina V Hartert
Journal:  J Allergy Clin Immunol       Date:  2017-05-04       Impact factor: 10.793

9.  In vivo toxicometabolomics reveals multi-organ and urine metabolic changes in mice upon acute exposure to human-relevant doses of 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Ana Margarida Araújo; Márcia Carvalho; Vera Marisa Costa; José Alberto Duarte; Ricardo Jorge Dinis-Oliveira; Maria de Lourdes Bastos; Paula Guedes de Pinho; Félix Carvalho
Journal:  Arch Toxicol       Date:  2020-11-19       Impact factor: 5.153

10.  Biomarker Discovery and Translation in Metabolomics.

Authors:  G A Nagana Gowda; D Raftery
Journal:  Curr Metabolomics       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.